Investor mix
3 investors on record; lead investors include Takeda, 8VC, Arch Venture Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |
Developer of RNA-based therapeutics to treat cancer and rare diseases
3 investors on record; lead investors include Takeda, 8VC, Arch Venture Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |